We evaluated each of the nine previously unreported loci that we detect here for association in prior adiponectin GWAS meta-analyses from ADIPOGen14 and AGEN19 and with other cardiometabolic traits and diseases. For these traits, we examined existing genome- and exome-wide meta-analysis results from consortia including GIANT (BMI26 and waist-to-hip-ratio adjusted for BMI36), GLGC (total cholesterol, HDL, LDL, and triglycerides),25 T2D,21 and MAGIC (HbA1c, fasting insulin, fasting glucose, 2-hour glucose).37, 38, 39, 40 We also examined the UK Biobank for associations with cardiometabolic traits and diseases. In addition, PhenoScanner was used to perform a PheWAS on all available traits, plasma proteins, and metabolites. We report proteins and metabolites when the lead exome variant and the variant most strongly associated with the protein or metabolite within 1 Mb exhibit high pairwise LD (r2 > 0.80). We did not identify any plasma proteins that met our criteria.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.